High event-free (EFS) and overall survival (OS) after non-total body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL): Results from the EndRAD trial (PTCTC ONC1701)Hisham Abdel-Azim, Michael A. Pulsipher, Troy C. Quigg et al.|Blood|2025Cited by 2
Outcomes Following Graft Failure and Second Subsequent Allogeneic Hematopoietic Cell Transplant in Patients with Sickle Cell Disease: A Multicenter StudyHemalatha G. Rangarajan, Allistair Abraham, Moshen Alzaharani et al.|Transplantation and Cellular Therapy|2026Cited by 1